Found: 6
Select item for more details and to access through your institution.
MEG3 affects the progression and chemoresistance of T‐cell lymphoblastic lymphoma by suppressing epithelial‐mesenchymal transition via the PI3K/mTOR pathway.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 5, p. 8144, doi. 10.1002/jcb.28093
- By:
- Publication type:
- Article
The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma.
- Published in:
- International Journal of Oncology, 2021, v. 58, n. 2, p. 275
- By:
- Publication type:
- Article
Family Aggregation of Hematological Malignancies Discovered from an Acute Myeloid Leukemia Patient with STK11 and THBD Gene Mutation.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 734, doi. 10.1159/000532003
- By:
- Publication type:
- Article
Whole genome, exon mutation and transcriptomic profiling of acute myeloid leukemia: A case report.
- Published in:
- Oncology Letters, 2021, v. 22, n. 1, p. N.PAG, doi. 10.3892/ol.2021.12820
- By:
- Publication type:
- Article
Inhibition of microRNA-221-5p induces osteogenic differentiation by directly targeting smad3 in myeloma bone disease mesenchymal stem cells.
- Published in:
- Oncology Letters, 2019, v. 18, n. 6, p. 6536, doi. 10.3892/ol.2019.10992
- By:
- Publication type:
- Article
miR-203a-3p.1 is involved in the regulation of osteogenic differentiation by directly targeting Smad9 in MM-MSCs.
- Published in:
- Oncology Letters, 2019, v. 18, n. 6, p. 6339, doi. 10.3892/ol.2019.10994
- By:
- Publication type:
- Article